European equities traded in the US as American depositary receipts were tracking higher late Tuesday morning, rising 0.82% to 1,901.23 on the S&P Europe Select ADR Index.
From continental Europe, the gainers were led by biotech firm Evaxion (EVAX) and biopharmaceutical company argenx (ARGX), which rose 9.9% and 6.3% respectively. They were followed by biopharmaceutical company DBV Technologies (DBVT) and medical device maker EDAP TMS (FOCL), which were up 6.7% and 4.2% respectively.
The decliners from continental Europe were led by petroleum refiner Equinor (EQNR) and oil and gas company Eni (E), which fell 2.5% and 1.3% respectively.
The gainers from the UK were led by software firm Endava (DAVA) and biopharmaceutical company Bicycle Therapeutics (BCYC), which advanced 7% and 4.7% respectively. They were followed by utilities company National Grid (NGG) and biopharmaceutical company NuCana (NCNA), which climbed 2.5% and 2.3% respectively.
The decliners from the UK and Ireland were led by biotech firm Trinity Biotech (TRIB) and mining company BHP Group (BHP), which dropped 4.3% and 1.6% respectively. They were followed by oil and gas company BP (BP) and communications company WPP (WPP), which lost 1.6% and 0.4% respectively.
Source: finance.yahoo.com — article syndicated from the publisher’s feed; all rights remain with the original publisher.
